COMP <GO>
RS vs BRK-A // EV/EBITDA & P/E VALUATION
Reliance Inc. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: RS 7
— BRK-A 6
▲ EV/EBITDA & P/E VALUATION LEADER: BRK-A
LAST: $436.91 (-0.64%) • MKT CAP: $22.40B
valuation
18.3x
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
valuation
12.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RS VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RS | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.60% | 8.30% | +1.30 | RS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.3x | 12.7x | +5.60 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 2.24% | 2.08% | +0.16 | RS | /fcf-yield <GO> |
| Operating Margin | 7.10% | 33.00% | -25.90 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 5.20% | 27.10% | -21.90 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 3.30% | -1.00% | +4.30 | RS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.27 | 3.02 | +4.25 | RS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | RS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.30% | -0.80 | RS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.1 | 67.2 | +3.94 | RS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.13 | -0.24 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.2x | 16.7x | +11.50 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.40B | $1.20T | -$1.18T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RS REV | BRK-A REV | RS GROSS % | BRK-A GROSS % | RS FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.29B | $247.24B | 44.0% | 44.0% | $502.5M | $25.04B |
| FY 2024 | $13.84B | $249.71B | 44.0% | 44.0% | $999.2M | $11.62B |
| FY 2023 | $14.81B | $254.91B | 44.0% | 44.0% | $1.01B | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RS // BETA 0.89
BRK-A // BETA 1.13